U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07801456) titled 'A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult Participants Without HIV' on Aug. 31.
Brief Summary: This study is to test an experimental HIV Vaccine. About 12 participants, aged 18-55 years and who already have cytomegalovirus (CMV) will take part in this study. Participants will come to the clinic for scheduled visits about 21 times over 12 months.
Study Start Date: Oct. 15
Study Type: INTERVENTIONAL
Condition:
Cytomegalovirus (CMV)
HIV (Human Immunodeficiency Virus)
Intervention:
BIOLOGICAL: VIR-1388
Treatment 1 (T1): VIR-1388, 6.9 x 10...